Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas M Carter

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2019
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric TumorsPatrícia M R Pereira, Komal Mandleywala, Ashwin Ragupathi, et al.
Physics in Medicine and Biology|July 29, 2025
Analytical positron range model for PET with cross-code Monte Carlo benchmarkingRobert J Paneque-Yunta, Nerea Encina-Baranda, Lukas M Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Leveraging Bioorthogonal Click Chemistry to Improve <sup>225</sup>Ac-Radioimmunotherapy of Pancreatic Ductal AdenocarcinomaSophie Poty, Lukas M Carter, Komal Mandleywala, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [<sup>89</sup>Zr]ZrCl<sub>4</sub>Serge K Lyashchenko, Tullio V Esposito, Tuan Tran, et al.
Medical Physics|September 1, 2023
The risk index as a basis for risk/benefit analyses and protocol optimization in diagnostic nuclear imagingJuan C Ocampo Ramos, Lukas M Carter, Justin L Brown, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2023
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic RadiopharmaceuticalsLukas M Carter, Juan C Ocampo Ramos, Edmond A Olguin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast CancerJustin Hachey, Tara D Viray, Sebastian E Carrasco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2023
<sup>212</sup>Pb-Pretargeted Theranostics for Pancreatic CancerDavid Bauer, Lukas M Carter, Mohamed I Atmane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian CancerKyeara N Mack, Zachary V Samuels, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2023
Dosimetric variability across a library of computational tumor phantomsLukas M Carter, Simone Krebs, Harry Marquis, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2019
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric TumorsPatrícia M R Pereira, Komal Mandleywala, Ashwin Ragupathi, et al.
Physics in Medicine and Biology|July 29, 2025
Analytical positron range model for PET with cross-code Monte Carlo benchmarkingRobert J Paneque-Yunta, Nerea Encina-Baranda, Lukas M Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Leveraging Bioorthogonal Click Chemistry to Improve <sup>225</sup>Ac-Radioimmunotherapy of Pancreatic Ductal AdenocarcinomaSophie Poty, Lukas M Carter, Komal Mandleywala, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [<sup>89</sup>Zr]ZrCl<sub>4</sub>Serge K Lyashchenko, Tullio V Esposito, Tuan Tran, et al.
Medical Physics|September 1, 2023
The risk index as a basis for risk/benefit analyses and protocol optimization in diagnostic nuclear imagingJuan C Ocampo Ramos, Lukas M Carter, Justin L Brown, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2023
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic RadiopharmaceuticalsLukas M Carter, Juan C Ocampo Ramos, Edmond A Olguin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast CancerJustin Hachey, Tara D Viray, Sebastian E Carrasco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2023
<sup>212</sup>Pb-Pretargeted Theranostics for Pancreatic CancerDavid Bauer, Lukas M Carter, Mohamed I Atmane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian CancerKyeara N Mack, Zachary V Samuels, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2023
Dosimetric variability across a library of computational tumor phantomsLukas M Carter, Simone Krebs, Harry Marquis, et al.
Pageof 7